• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝肾综合征的最新进展

Recent advances in hepatorenal syndrome.

作者信息

Arroyo Vicente, Torre Aldo, Guevara Mónica

机构信息

Liver Unit, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi-Sunyer, University of Barcelona School of Medicine, Barcelona, Catalunya, Spain.

出版信息

Trop Gastroenterol. 2005 Jan-Mar;26(1):13-20.

PMID:15974232
Abstract

Hepatorenal syndrome is a common complication of advanced cirrhosis, characterized by renal failure and major disturbances in circulatory function. Renal failure is caused by intense vasoconstriction of the renal circulation. The syndrome is probably the final consequence of extreme underfilling of the arterial circulation secondary to arterial vasodilatation in the splanchninc vascular bed. The diagnosis of HRS is currently based on the exclusion of other causes of renal failure. The prognosis is very poor, particularly when there is rapidly progressive renal failure (type 1). Liver transplantation is the best option in patients without contraindications to the procedure, but it is not always possible owing to the short survival expectancy. Therapies introduced during the past few years, such a vasoconstrictor drugs (vasopressin analogues, mu-adrenergic agonist) or the transjugular intrahepatic portosystemic shunt, are effective in improving renal function. Nevertheless, liver transplantation should still be done in suitable patients even after improvement of renal function because the outcome of HRS is poor.

摘要

肝肾综合征是晚期肝硬化的常见并发症,其特征为肾衰竭和循环功能的严重紊乱。肾衰竭由肾循环的强烈血管收缩引起。该综合征可能是由于内脏血管床动脉血管扩张继发动脉循环极度充盈不足的最终结果。肝肾综合征的诊断目前基于排除其他肾衰竭原因。预后非常差,尤其是在出现快速进行性肾衰竭(1型)时。对于无该手术禁忌证的患者,肝移植是最佳选择,但由于预期生存期短,并非总是可行。过去几年引入的治疗方法,如血管收缩剂药物(血管加压素类似物、μ-肾上腺素能激动剂)或经颈静脉肝内门体分流术,在改善肾功能方面有效。然而,即使肾功能改善后,仍应在合适的患者中进行肝移植,因为肝肾综合征的预后较差。

相似文献

1
Recent advances in hepatorenal syndrome.肝肾综合征的最新进展
Trop Gastroenterol. 2005 Jan-Mar;26(1):13-20.
2
New treatments of hepatorenal syndrome.肝肾综合征的新疗法。
Semin Liver Dis. 2006 Aug;26(3):254-64. doi: 10.1055/s-2006-947293.
3
Diagnosis and treatment of hepatorenal syndrome.肝肾综合征的诊断与治疗
Baillieres Best Pract Res Clin Gastroenterol. 2000 Dec;14(6):945-57. doi: 10.1053/bega.2000.0140.
4
Hepatorenal syndrome.肝肾综合征
Lancet. 2003 Nov 29;362(9398):1819-27. doi: 10.1016/S0140-6736(03)14903-3.
5
Hepatorenal syndrome: a dreaded complication of end-stage liver disease.肝肾综合征:终末期肝病的一种可怕并发症。
Am J Gastroenterol. 2005 Feb;100(2):460-7. doi: 10.1111/j.1572-0241.2005.40952.x.
6
Therapy insight: Management of hepatorenal syndrome.治疗洞察:肝肾综合征的管理
Nat Clin Pract Gastroenterol Hepatol. 2006 Jun;3(6):338-48. doi: 10.1038/ncpgasthep0517.
7
Pathophysiology and treatment of hepatorenal syndrome.肝肾综合征的病理生理学与治疗
Gastroenterologist. 1998 Jun;6(2):122-35.
8
Review article: pharmacological treatment of hepatorenal syndrome.综述文章:肝肾综合征的药物治疗
Aliment Pharmacol Ther. 2004 Sep;20 Suppl 3:57-62; discussion 63-4. doi: 10.1111/j.1365-2036.2004.02115.x.
9
Hepatorenal syndrome.肝肾综合征
Semin Liver Dis. 1997;17(3):233-47. doi: 10.1055/s-2007-1007201.
10
[Hepatorenal syndrome].[肝肾综合征]
Srp Arh Celok Lek. 2007 Jan-Feb;135(1-2):98-104.